Filing Details
- Accession Number:
- 0000899243-20-027723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-07 17:01:36
- Reporting Period:
- 2020-10-05
- Accepted Time:
- 2020-10-07 17:01:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1563577 | Galera Therapeutics Inc. | GRTX | Pharmaceutical Preparations (2834) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227367 | T Jon Holmlund | C/O Galera Therapeutics, Inc., 2 W Liberty Blvd #100 Malvern PA 19355 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-05 | 100 | $1.07 | 100 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-10-05 | 100 | $12.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-10-06 | 4,904 | $1.07 | 4,904 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-10-06 | 5,632 | $1.14 | 5,632 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-10-06 | 10,536 | $12.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2020-10-05 | 100 | $0.00 | 100 | $1.07 |
Common Stock | Stock Option | Disposition | 2020-10-06 | 4,904 | $0.00 | 4,904 | $1.07 |
Common Stock | Stock Option | Disposition | 2020-10-06 | 5,632 | $0.00 | 5,632 | $1.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,904 | 2023-01-26 | No | 4 | M | Direct | |
0 | 2023-01-26 | No | 4 | M | Direct | |
0 | 2024-09-16 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- The option has fully vested and is currently exercisable.
- The option has fully vested and is currently exercisable.